Salovich; James M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Salovich; James M..The latest application filed is for "substituted indole mcl-1 inhibitors".

Company Profile

5.19.16

Salovich; James M. - Nashville TN
Salovich; James M - Nashville TN
Salovich; James M. - Durham NC
Salovich; James M - Durham NC
Salovich; James M. - Cary NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Indole Mcl-1 Inhibitors App 20210283138 - Lee; Taekyu ; et al.	2021-09-16
WDR5-MLL1 inhibitors and modulators Grant 10,807,959 - Gogliotti , et al. October 20, 2	2020-10-20
Wdr5-mll1 Inhibitors And Modulators App 20200055824 - Gogliotti; Rocco D. ; et al.	2020-02-20
WDR5 inhibitors and modulators Grant 10,501,466 - Fesik , et al. Dec	2019-12-10
Substituted benzimidazoles as modulators of Ras signaling Grant 10,501,421 - Fesik , et al. Dec	2019-12-10
Wdr5 Inhibitors And Modulators App 20190084988 - Fesik; Stephen W. ; et al.	2019-03-21
Substituted 5-aminothieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 Grant 9,868,746 - Lindsley , et al. January 16, 2	2018-01-16
Substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide Analogs As Positive Allosteric Modulators Of The Muscarinic Acetylcholine Receptor M4 App 20170022216 - Lindsley; Craig W. ; et al.	2017-01-26
Substituted 5-aminothieno[2,3--C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 Grant 9,493,481 - Lindsley , et al. November 15, 2	2016-11-15
Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Grant 9,192,603 - Conn , et al. November 24, 2	2015-11-24
Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Grant 9,163,015 - Conn , et al. October 20, 2	2015-10-20
Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Grant 9,108,963 - Conn , et al. August 18, 2	2015-08-18
Substituted pyrazolo[3',4':4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 Grant 9,056,875 - Lindsley , et al. June 16, 2	2015-06-16
Substituted 1H-pyrazolo[3',4',4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 Grant 9,056,876 - Conn , et al. June 16, 2	2015-06-16
Substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide Analogs As Positive Allosteric Modulators Of The Muscarinic Acetylcholine Receptor M4 App 20150018309 - Lindsley; Craig W ; et al.	2015-01-15
Substituted Pyrazolo[3',4':4,5]thieno[2,3-c]pyridazin-3-amine Analogs As Positive Allosteric Modulators Of The Muscarinic Acetylcholine Receptor M4 App 20140364409 - Lindsley; Craig W. ; et al.	2014-12-11
Substituted 1h-pyrazolo[3',4',4,5]thieno[2,3-b]pyridin-3-amine Analogs As Positive Allosteric Modulators Of The Muscarinic Acetycholine Receptor M4 App 20140357615 - Conn; Jeffrey P. ; et al.	2014-12-04
MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Grant 8,779,157 - Conn , et al. July 15, 2	2014-07-15
Heterocyclic Sulfone MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction App 20130158078 - Conn; P. Jeffrey ; et al.	2013-06-20
Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction App 20130096110 - Conn; P. Jeffrey ; et al.	2013-04-18
Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction App 20130065895 - Conn; P. Jeffrey ; et al.	2013-03-14
Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction App 20120245153 - Conn; P. Jeffrey ; et al.	2012-09-27
Imidazopyridine kinase inhibitors Grant 8,093,239 - Kuntz , et al. January 10, 2	2012-01-10
Benzimidazole thiophene compounds Grant 7,595,330 - Cheung , et al. September 29, 2	2009-09-29
Pyrimidine compounds Grant 7,514,446 - Davis-Ward , et al. April 7, 2	2009-04-07
Imidazopyridine Kinase Inhibitors App 20080300242 - Kuntz; Kevin ; et al.	2008-12-04
Benzimidazole Thiophene Compounds App 20070270437 - Cheung; Mui ; et al.	2007-11-22
Aminobutanoic acid compounds having metalloprotease inhibiting properties Grant 5,326,760 - McElroy , et al. July 5, 1	1994-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.